Expression of p27KIP1 in human gliomas: Relationship between tumor grade, proliferation index, and patient survival

Human Pathology

Volumn 34, Issue 1, 2003, Pages 48-53

  Zagzag, David ^a   Blanco, Cy ^a   Friedlander, David R ^a   Miller, Douglas C ^a   Newcomb, Elizabeth W ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glioma; p27KIP1; Proliferation index; Survival; Tumor grade

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P27;

ADULT; AGE; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; NECROSIS; PATHOGENESIS; PROTEIN EXPRESSION; TUMOR CELL; WESTERN BLOTTING;

EID: 0037255943     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2003.54     Document Type: Article

References (36)

1. Steeg PS, Abrams JS: Cancer prognostics: Past, present and p27. Nat Med 3:152-154, 1997
2. Slingerland J, Pagano M: Regulation of the Cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 183:10-17, 2000
3. Lloyd RV, Erickson LA, Jin L, et al: p27kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 154:313-323, 1999
4. Porter PL, Malone KE, Heagerty PJ, et al: Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3:222-225, 1997
5. Catzavelos C, Bhattacharya N, Ung YC, et al: Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer. Nat Med 3:227-230, 1997
6. Mori M, Mimori K, Shiraishi T, et al: p27 expression and gastric carcinoma. Nat Med 3:593, 1997
7. Cordon-Cardo C, Koff A, Drobnjak M, et al: Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. J Natl Cancer Inst 90:1284-1291, 1998
8. Kawana H, Tamaru J, Tanaka T, et al: Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer. Am J Pathol 153:505-513, 1998
9. Newcomb EW, Sosnow M, Demopoulos RI, et al: Expression of the cell cycle inhibitor p27KIP1 is a new prognostic marker associated with survival in epithelial ovarian tumors. Am J Pathol 154:119-125, 1999
10. Loda M, Cukor B, Tam SW, et al: Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 3:231-234, 1997
11. Thomas GV, Szigeti K, Murphy M, et al: Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Am J Pathol 153:681-687, 1998
12. Palmqvist R, Stenling R, Oberg A, et al: Prognostic significance of p27(Kip1) expression in colorectal cancer: A clinico-pathological characterization. J Pathol 188:18-23, 1999
13. Lloyd RV, Jin L, Qian X, et al: Aberrant p27kip1 expression in endocrine and other tumors. Am J Pathol 150:401-407, 1997
14. Jordan RC, Bradley G, Slingerland J: Reduced levels of the cell-cycle inhibitor p2Kip1 in epithelial dysplasia and carcinoma of the oral cavity. Am J Pathol 152:585-590, 1998
15. Pagano M, Tam SW, Theodoras AM, et al: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685, 1995
16. Piva R, Cavalla P, Bortolotto S, et al: p27/kip1 expression in human astrocytic gliomas. Neurosci Lett 234:127-130, 1997
17. Piva R, Cancelli I, Cavalla P, et al: Proteasome-dependent degradation of p27/kip1 in gliomas. J Neuropathol Exp Neurol 58:691-696, 1999
18. Mizumatsu S, Tamiya T, Ono Y, et al: Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma. Clin Cancer Res 5:551-557, 1999
19. Fuse T, Tanikawa M, Nakanishi M, et al: p27Kip1 expression by contact inhibition as a prognostic index of human glioma. J Neurochem 74:1393-1399, 2000
20. Ehrmann J, Collan Y, Rihakova P, et al: Apoptosis, analyzed by means of lamin B detection, correlates with grade of astroglial tumours but not with p27kip1/retinoblastoma protein expression. Virchows Arch 439:547-551, 2001
21. Naumann U, Weit S, Rieger L, et al: p27 modulates cell cycle progression and chemosensitivity in human malignant glioma. Biochem Biophys Res Commun 261:890-896, 1999
22. Nakasu S, Nakajima M, Handa J: Anomalous p27Kip1 expression in a subset of malignant gliomas. Brain Tumor Pathol 16: 17-21, 1999
23. Alleyne CH, He J, Yang J, et al: Analysis of cyclin dependent kinase inhibitors in malignant astrocytomas. Int J Oncol 14:1111-1116, 1999
24. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 3:255-268, 1993
25. Zagzag D, Friedlander DR, Miller DC, et al: Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res 55:907-914, 1995
26. Yatabe Y, Masuda A, Koshikawa T, et al: p27KIP1 in human lung cancers: Differential changes in small cell and non-small cell carcinomas. Cancer Res 58:1042-1047, 1998
27. Masuda A, Osada H, Yatabe Y, et al: Protective function of p27KIP1 against apoptosis in small cell lung cancer cells in unfavorable microenvironments. Am J Pathol 158:87-96, 2001
28. Zagzag D, Zhong H, Scalzitti JM, et al: Expression of hypoxiainducible factor 1α in human brain tumors: Association with angiogenesis, invasion and progression. Cancer 88:2606-2618, 2000
29. Carmeliet P, Dor Y, Herbert JM, et al: Role of HIF-1 in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394:485-490, 1998
30. Gardner LB, Li Q, Park MS, et al: Hypoxia inhibits G1/S transition through regulation of p27 expression. J Biol Chem 276: 7919-7926, 2001
31. Krtolica A, Krucher NA, Ludlow JW: Molecular analysis of selected cell cycle regulatory proteins during aerobic and hypoxic maintenance of human ovarian carcinoma cells. Br J Cancer 80:1875-1883, 1999
32. Fujii T, Otsuki T, Moriya T, et al: Effect of hypoxia on human seminoma cells. Int J Oncol 20:955-962, 2002
33. Newcomb EW, Cohen H, Lee SR, et al: Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes. Brain Pathol 8:655-667, 1998
34. Daumas-Duport C, Scheithauer BW, Kelly PJ: A histologic and cytologic method for the spatial definition of gliomas. Mayo Clin Proc 62:435-449, 1987
35. Cunningham JM, Kimmel DW, Scheithauer BW, et al: Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: Relationships and prognostic value. J Neurosurg 86:121-130, 1997
36. Pomeroy S, Tamayo P, Gaasenbeek M, et al: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436-442, 2002